HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/4/E758    most recent 00581.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Harmon, A. W. Articles by Patel, Y. M. Search for Related Content PubMed PubMed Citation Articles by Harmon, A. W. Articles by Patel, Y. M.

MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes

Department of Nutrition, University of North Carolina School of Public Health, Chapel Hill, North Carolina 27599

Submitted 22 December 2003 ; accepted in final form 28 May 2004

In 3T3-L1 adipocytes, insulin activates three major signaling cascades, the phosphoinositide 3-kinase (PI3K) pathway, the Cbl pathway, and the mitogen-activated protein kinase (MAPK) pathway. Although PI3K and Cbl mediate insulin-stimulated glucose uptake by promoting the translocation of the insulin-responsive glucose transporter (GLUT4) to the plasma membrane, the MAPK pathway does not have an established role in insulin-stimulated glucose uptake. We demonstrate in this report that PI3K inhibitors also inhibit the MAPK pathway. To investigate the role of the MAPK pathway separately from that of the PI3K pathway in insulin-stimulated glucose uptake, we used two specific inhibitors of MAPK kinase (MEK) activity, PD-98059 and U-0126, which reduced insulin-stimulated glucose uptake by 33 and 50%, respectively. Neither MEK inhibitor affected the activation of Akt or PKC/, downstream signaling molecules in the PI3K pathway. Inhibition of MEK with U-0126 did not prevent GLUT4 from translocating to the plasma membrane, nor did it inhibit the subsequent docking and fusion of GLUT4-myc with the plasma membrane. MEK inhibitors affected glucose transport mediated by GLUT4 but not GLUT1. Importantly, the presence of MEK inhibitors only at the time of the transport assay markedly impaired both insulin-stimulated glucose uptake and MAPK signaling. Conversely, removal of MEK inhibitors before the transport assay restored glucose uptake and MAPK signaling. Collectively, our studies suggest a possible role for MEK in the activation of GLUT4.

p44/p42 mitogen-activated protein kinase; glucose transporter 4; glucose transport; U-0126; PD-98059

This article has been cited by other articles:

				Z. Wang, H. Jin, C. Li, Y. Hou, Q. Mei, and D. Fan Heat Shock Protein 72 Protects Kidney Proximal Tubule Cells From Injury Induced by Triptolide by Means of Activation of the MEK/ERK Pathway International Journal of Toxicology, May 1, 2009; 28(3): 177 - 189. [Abstract] [Full Text] [PDF]

				O. Bezy, C. Vernochet, S. Gesta, S. R. Farmer, and C. R. Kahn TRB3 Blocks Adipocyte Differentiation through the Inhibition of C/EBP{beta} Transcriptional Activity Mol. Cell. Biol., October 1, 2007; 27(19): 6818 - 6831. [Abstract] [Full Text] [PDF]